149 related articles for article (PubMed ID: 8758257)
1. Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks.
Andreuccetti M; Allegrini G; Antonuzzo A; Malvaldi G; Conte PF; Danesi R; Del Tacca M; Falcone A
Eur J Cancer; 1996 Jun; 32A(7):1219-26. PubMed ID: 8758257
[TBL] [Abstract][Full Text] [Related]
2. Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.
Falcone A; Lencioni M; Brunetti I; Pfanner E; Allegrini G; Antonuzzo A; Andreuccetti M; Malvaldi G; Danesi R; Del Tacca M; Conte PF
Ann Oncol; 1997 Jun; 8(6):539-45. PubMed ID: 9261522
[TBL] [Abstract][Full Text] [Related]
3. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
4. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.
Yasuda C; Kato M; Kuroda D; Ohyanagi H
Jpn J Cancer Res; 1997 Jan; 88(1):97-102. PubMed ID: 9045902
[TBL] [Abstract][Full Text] [Related]
6. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
Zhen YS; Taniki T; Weber G
Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
[TBL] [Abstract][Full Text] [Related]
7. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
Johnston PG; Geoffrey F; Drake J; Voeller D; Grem JL; Allegra CJ
Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
[TBL] [Abstract][Full Text] [Related]
8. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
Pressacco J; Erlichman C
Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
Darnowski JW; Davol PA; Goulette FA
Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
[TBL] [Abstract][Full Text] [Related]
11. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trial.
Posner MR; Darnowski JW; Weitberg AB; Dudley MN; Corvese D; Cummings FJ; Clark J; Murray C; Clendennin N; Bigley J
Cancer; 1992 Dec; 70(12):2929-34. PubMed ID: 1451076
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and biochemical implications of combining AZT and AG-331.
Pressacco J; Mitrovski B; Erlichman C
Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic interactions of 5-fluorouracil and nucleoside analogues in vitro.
Li YX; Coucke PA; Paschoud N; Mirimanoff RO
Anticancer Res; 1997; 17(1A):21-7. PubMed ID: 9066626
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines.
Schiller JH; Bittner G
Int J Cancer; 1990 Jul; 46(1):61-6. PubMed ID: 2114374
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Brown T; Sigurdson E; Rogatko A; Broccoli D
Ann Surg Oncol; 2003 Oct; 10(8):910-5. PubMed ID: 14527910
[TBL] [Abstract][Full Text] [Related]
17. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
18. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Subbarayan PR; Lee K; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
[TBL] [Abstract][Full Text] [Related]
20. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
Darnowski JW; Goulette FA
Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
